CelGro Study Results Open Up New US Market Access Strategy
Filed with ASX · · 4 pages · English
• US 510(k) pilot animal study results indicate CelGro® facilitates superior nerve regeneration when compared to the market leading nerve repair device,restoring the sciatic nerve to its pre- injured state with no adverse reactions; • Pilot study provides critical insights into CelGro®’s mode of action in nerve regeneration and underpins the consistent restoration of arm and hand function to paral
Earlier from Orthocell
- CelGro gains Australian reimbursement
- Orthocell receives new US patent for CelGro
- CelGro Recommended for Reimbursement
- Orthocell Receives A$2.3m R&D Tax Incentive Refund
- Orthocell Receives US Market Clearance
Later from Orthocell
- New Collagen Rope Patent for CelGro Platform Technology
- OCC Secures Patents for Sutureless Repair of Soft Tissue
- Positive CelGro Nerve Regeneration Results
- Orthocell Appoints Exclusive Distributor in Australia
- CelGro Facilitates Lymphatic Vessel Regeneration
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell